US Federal House Bill HB8679

US Federal 2025-2026 Regular Session

• Introduced: 5/7/26
• Refer: 5/7/26

Caption

To amend title 38, United States Code, to require the Secretary of Veterans Affairs to transmit a veteran's history of opioid prescriptions to a Community Care health care provider.

Summary

HB8679 would amend title 38 of the U.S. Code to require the Department of Veterans Affairs to transmit a covered veteran’s history of opioid prescriptions when the veteran receives care from a non-VA Community Care provider. The bill directs the Secretary of Veterans Affairs to ensure that this prescription history is shared as part of the standards governing VA-furnished community care, and that the information is sent through a Third Party Administrator. The measure is narrowly focused on improving medication history sharing between VA records and outside providers treating veterans under the Community Care program. By requiring transmission of opioid prescription histories, the bill is intended to help outside clinicians make safer prescribing and treatment decisions, reduce the risk of duplicate or conflicting opioid therapy, and improve continuity of care for veterans who receive services outside the VA system.

Impact

If enacted, the bill would amend section 1703C of title 38, United States Code, by adding a new requirement for VA community care standards to include transmission of opioid prescription histories to non-Department providers and through Third Party Administrators. It would also add a definition cross-reference for “Third Party Administrator” to align with existing VA community care law. The practical effect would be to impose a new information-sharing obligation on the Department of Veterans Affairs and its community care administrative partners, while affecting non-VA providers who treat covered veterans under section 1703.

Sentiment

The available record shows no committee transcript, recorded vote, or other debate, so there is no documented opposition or support beyond the bill’s introduction and referral. Based on the bill’s text and purpose, the measure appears to be a targeted patient-safety and care-coordination proposal rather than a broad policy change. The absence of recorded controversy suggests the bill was, at minimum, introduced in a relatively straightforward manner without publicized disagreement in the materials provided.

Contention

No specific points of contention are documented in the provided materials because there are no committee discussions or votes. Potential areas of concern, if raised later, would likely center on privacy, data-sharing logistics, administrative burden on VA and Third Party Administrators, and whether the requirement should be limited to opioid histories rather than broader medication records. Any such concerns are not reflected in the current record, which only shows referral to the House Committee on Veterans’ Affairs.